Press Release
Category Added in a WPeMatico Campaign
-
Adecoagro to Expand its S&E Cluster in Mato Grosso do Sul via Acquisition of Caarapó mill
LUXEMBOURG, July 20, 2026 /PRNewswire/ — Adecoagro S.A. (NYSE: AGRO) (“Adecoagro” or the “Company”), a leading sustainable production company in…
Read More » -
ACL Digital Announces Strategic Alliance with Swantide to Fast-Track AI-Driven Salesforce Delivery
The partnership combines ACL Digital’s chip-to-cloud engineering expertise with Swantide’s AI-native Salesforce platform to drive measurable enterprise outcomes. SAN JOSE,…
Read More » -
Biohaven to Present New Clinical Data at ESMO Congress on BHV-1530, a Novel FGFR3-Directed ADC With a Proprietary Topoisomerase I (TopoIx) Payload
Biohaven also announces new clinical supply agreement with Regeneron to evaluate BHV-1530 in combination with cemiplimab (Libtayo®) Early clinical activity…
Read More » -
AI or Not Detects 100% of Meta AI Images and Holds 98% Accuracy After Those Images Are Cropped or Tampered
New AI or Not benchmark shows the company’s purpose-built detection stays accurate on cropped and tampered images, corroborated by an…
Read More » -
5TH ANNUAL TECHCHICAGO WEEK TO GATHER MORE THAN 15,000 FOUNDERS, INVESTORS & TECH WORKERS
Chicago’s largest tech gathering features 13 main events including the second annual Global Quantum Forum and over 130 partner events…
Read More » -
Reins expands into Canada, bringing alternative equity solutions to independent businesses
Company builds on US success by helping Canadian business owners retain key employees and prepare for succession without giving up…
Read More » -
Marengo Secures ESMO 2026 Oral Presentation for Key Phase 2 Invikafusp Alfa Data in PD-1-Resistant Solid Tumors and Appoints Pembrolizumab Development Leader Eric Rubin, M.D., to Scientific Advisory Board
Updated STARt-001 results will highlight invikafusp alfa’s single-agent activity in PD-1–resistant tumors using a biomarker-enrichment strategy Eric Rubin, former Senior…
Read More » -
MiniMed to Announce Its Fiscal Year 2027 First Quarter Financial Results
NORTHRIDGE, Calif., July 20, 2026 /PRNewswire/ — MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced that it…
Read More » -
Medtronic to announce financial results for its first quarter of fiscal year 2027
GALWAY, Ireland, July 20, 2026 /PRNewswire/ — Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that…
Read More » -
Armata Pharmaceuticals Achieves Key Progress Across Clinical, Regulatory and Manufacturing Activities Supporting Planned Phase 3 Initiation of AP-SA02
FDA submissions address all feedback on clinical, CMC, and regulatory topics from the End-of-Phase 2 meeting Four AP-SA02 engineering runs…
Read More »